Company intelligence / Profile preview
LG Chem
Seoul, South Korealgchem.com ↗
- Ownership
- Public · 051910
- Employees
- ~18750
- Development stage
- Commercial
01
Overview
LG Chem’s Life Sciences division has achieved several firsts in Korea’s pharmaceutical industry—including the first US FDA-approved Korean NCE—and maintains a broad portfolio of commercialized drugs spanning diabetes, growth disorders, vaccines, aesthetics/fillers, and more. The company has expanded globally through acquisitions like AVEO Pharmaceuticals and partnerships with companies such as Rhythm Pharmaceuticals. Its pipeline includes innovative therapies targeting oncology/immunology/metabolic disease at various stages from preclinical to late-stage clinical development.[2][9]
- Therapeutic areas
- Metabolic DisordersRheumatologyEndocrinologyDermatologyWomen's HealthOncologyInfectious Diseases
- Modalities
- Small moleculesBiologics (including biosimilars, vaccines, and hyaluronic acid-based products)Fusion proteins (e.g., immuno-oncology programs)Microbiome therapeutics[7][4][6]
- Industry
- Biotech
02
Drug pipeline
55 assets54 more assets in the full pipeline.
Request access →03
Partnerships
Cue Biopharma – ImmunoSTAT platform collaboration for cancer immunotherapy development.Rhythm Pharmaceuticals – Outlicensing of oral MC4R agonist LB54640.Genome & Company – License agreement on GEN‑001 microbiome therapeutic.
Beyond the preview
Go deeper on LG Chem.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LG Chem.